Antidepressants: Drug Information

Personalized education in 30-60 minutes either in-person or via web conferencing (e.g., Zoom or WebEx) at a time and location that is convenient for you. This Group Learning program has been certified by the College of Family Physicians of Canada and the British Columbia Chapter for up to 1 Mainpro+ credits.

Learning objective

Participants will be able to thoughtfully prescribe, monitor and manage antidepressant therapy in their patients.

During the academic detailing visit, participants will have the opportunity to discuss:

  • How the efficacy of antidepressants is measured in clinical trials and synthesized in meta-analyses
  • The quality and quantity of evidence that informs conclusions regarding antidepressant comparisons and combinations, and
  • Drug information relevant to the prescribing, deprescribing and monitoring of antidepressants, including: dose response, adverse events, clinical toxicology, drug interactions, available dosage forms and ability to taper practically, and cost and coverage

After the academic detailing visit, participants will be able to:

  1. Choose an initial antidepressant informed by potential for adverse events, clinical toxicology, propensity for withdrawal symptoms, risk of drug interactions, ability to taper practically, and cost
  2. Apply evidence regarding antidepressant dose-response relationships
  3. Implement an antidepressant tapering strategy


When: Until March 3, 2022
Where: In-person or virtual academic detailing (individualized web or teleconference)
How: Contact your PAD pharmacist directly or email 


For more information about the PAD service, visit PAD Frequently Asked Questions.